Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars

Journal
Presentation
    （Last updated : 2022-07-02 11:35:05）
  Tamaki Hiroya
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 CD48 as a novel molecular target for antibody therapy in multiple myeloma 2012/01
2. Original article　 Donor-but not host-derived interluekin-10 contributes to the regulation of expertimental graft-versus-host disease 2012/04
3. Other　 Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation. 2012/08
4. Original article　 Difference in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study 2012/10
5. Original article　 Influence of donor microbiota on the severity of experimental graft-versus-host-disease. 2013/01
6. Original article　 PU.1-dependent transcriptional regulation of miR-142 contributes to its hematopoietic cell-specific expression and modulation of IL-6. 2013/04
7. Original article　 Frequency of CD4(+)FOXP3(+) regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD. 2013/06
8. Original article　 Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. 2013/07
9. Original article　 FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. 2013/09
10. Original article　 Neddylation plays an important role in the regulation of murine and human dendritic cell function. 2013/09
11. Original article　 Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. 2013/11
12. Original article　 Recombinant human soluble thrombomodulin attenuates FK506-induced endothelial dysfunction through prevention of Akt inactivation. 2014/04
13. Original article　 Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioning. 2014/04
14. Original article　 Unmanipulated HaploidenticalReduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan. 2015/08
15. Original article　 Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation. 2015/10
16. Original article　 Host Foxp3+CD4+ Regulatory T Cells Act as a Negative regulator of dendritic cells in the peritransplantation period. Journal of Immunology. 2016/01
17. Case report　 Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity. 2016/02
18. Original article　 Spousal hematopoietic stem cell transplantation 2017/05
19. Original article　 Siglec-G represses DAMP-mediated effects on T cells. 2017/07
20. Original article　 IAPs protect host target tissues from graft-versus-host disease in mice. 2017/08
21. Original article　 STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity. 2017/10
22. Original article　 Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation. 2018/12
23. Original article　 Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition. 2019/05
24. Original article　 Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
25. Original article　 Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. 2019/07
26. Original article　 Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP. 2019/09
27. Original article　 Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
Display 5 items
Display all(27)
■ Presentation
1. Hematopoietic stem cell transplantation using a related donor not sharing HLA-haplotype  2015/03/06
2. Maturation of dendritic cells restrained by host Foxp3+CD4+regulatory T cells: the critical role in the induction of graft-veusus-host reaction after experimental BMT.  2015/03/06
3. A case report with MDS who underwent haploindentical transplantation after umbilical cord blood transplantation with Mixed cheimerism state over a long period of time.  2016/03/04
4. Allogeneic Stem Cell Transplantation for X-linked agammaglobulinemia as a model of the reconstitution of humoral immunity  2016/03/04
5. clinical outcomes of HLA haploidentical hematopoietic stem cell transplantation in patients with Philadelphia Chromosome positive Acute Lymphoblastic Leukemia in our institute  2016/03/04
6. A case of cerebral toxoplasmosis and EBV-associated post-transplant lymphoproliferative disorder of the central nervous system following allogeneic hematopoietic stem cell transplantation  2017/03/02
7. One example of acute myeloid leukemia for severe hepatic dysfunction due to acute GVHD who underwent living donor liver transplantation from hematopoietic stem cell donor  2017/03/02
8. Study on citrate intozication during peripheral blood stem cell harvesting  2017/03/02
9. Association beteween plasma concentration of antithymocyte globulin(ATG) and acute graft versus host disease(GVHD) granding on haploidentical hematopoietic stem cell transplantation  2017/03/04
10. Siglec-G-CD24 pathway regulates DAMP mediated donor T cell activation.  2017/10/20
11. Prognostic value of WT1 on HLA-haploidentical RIST for non-remission leukemia  2018/02/02
12. Prediction of hemorrhagic cystitis using antibody to ADV type11 and prophylastic value of cidofovir  2018/02/03
13. Mitochondrial deacetylase SIRT3 regulates donor T cell activation in GVHD  2018/03/09
14. Detailed bone marrow plasma cell phenotyping in the patients with suspected plasma cell disorders.  2018/10/14
15. Dose CMV reactivation reduce AML relapse risk in HCM-style HLA-haploidentical RIST?  2019/03/08
16. Granulocyte collections using Spectra Optia with or without the use of hydroxyethy1 starch  2019/03/08
17. HLA haploidentical transpantation in AYAs  2019/03/08
18. Isohemagglotinin production after minor ABO-incompatible peripheral blood stem cell transplantation  2019/03/08
19. Steroid-resistant,homeostatically-proliferationg donor T cells in BM suppresses GVHD preserving GVL  2019/03/08
20. Usefulness of measuring hematology analyzer-based HPC in peripheral blood stem cell harvest  2019/03/08
21. Secondary malignancies after hematopoietic stem cell transplantation in Hyogo college of medicine  2019/03/09
22. anti-NMDAR encephalitis after HLA haploidentical stem cell transplantation  2020/03/06
23. NLRP6 regulates CD4 T cell mediated GVHD in ezperimental murine BMT  2020/03/06
24. Phamacokinetics of cidofovir in Japanese patients receiving hematopoietic stem cell transplantation  2020/03/06
25. Decision making in AYA patients with hematological malignancy underwent HLA mismatch transplants.  2021/03
26. Survival-time analysis using recurrent neural networks in hematopoietic stem cell transplantation  2021/03
27. Tisagenlecleucel for Diffuse Large B-cell Lymphoma:A Single Center Experience  2021/03
28. Association between the grade of cytokine release syndrome and cardiac dysfunction after chimeric antigen receptor T cell therapy for diffuse large B cell lymphoma patients.  2021/11/13
29. The Association between Grade of Cytokine Release Syndrome and Cardiac Dysfunction after Chimeric Antigen Receptor T Cell Therapy.  2022/03/12
Display 5 items
Display all(29)
mail